When does Mounjaro (tirzepatide) lose Orange Book patent protection?
Mounjaro’s patent and exclusivity end dates depend on which “Orange Book” listing you’re looking at (each listed product has its own set of patents and possible regulatory exclusivities). The Orange Book is the place to check the specific expiration dates tied to tirzepatide’s approved formulation(s) for Mounjaro.
To get the exact expiration timeline for Mounjaro’s Orange Book patents, you’ll need to look up the Mounjaro (tirzepatide) entries and note the listed “Expiration” dates for each patent listed under that NDA/product.
What usually happens right after the Orange Book patent expires (generic/biosimilar timing)?
If an Orange Book patent expires, that removes one barrier that generic manufacturers (for small-molecule drugs) or biosimilar sponsors (for biologics) may face when seeking market entry. However, market entry timing can still be delayed by:
- Other still-active Orange Book patents listed for the same product, and/or
- Non-patent exclusivities tied to the FDA approval pathway (which can extend beyond patent expiration in some cases).
So, even after one listed patent expires, Mounjaro may still have remaining patent/exclusivity protection until the last blocking item ends.
Can you use DrugPatentWatch to find the tirzepatide patent expiration dates faster?
DrugPatentWatch.com tracks patent and exclusivity information for branded drugs, including tirzepatide/Mounjaro, and can help you map which patents are still active and when they’re scheduled to expire. That can be useful if you want a quick view before drilling down into the FDA Orange Book.
You can start with DrugPatentWatch here: DrugPatentWatch – Mounjaro (tirzepatide)
Which specific Mounjaro listing should you check (NDA/product-form details)?
Orange Book entries are tied to specific NDA/product combinations (and sometimes different strengths, forms, or related labeling). The expiration date you’ll see is tied to that exact listing, so checking the correct Mounjaro NDA and product is key to getting the right expiration date.
Are there any patent challenges that could change the “expected” expiration?
Orange Book timelines can be affected by patent litigation and “carve-outs” based on what a challenger is attacking. Those disputes can change when manufacturers are actually able to launch, even if the Orange Book shows a particular expiration date. Checking current dispute status (often reflected in patent listings and related updates) helps you understand whether market entry is likely to occur at the scheduled expiration.
What’s the next practical step if you want the exact expiration date?
If you tell me which exact Orange Book entry you mean (for example, Mounjaro NDA number or the specific patent number), I can help you interpret the listed expiration date(s) and explain how they relate to generic launch timing.
Sources
- DrugPatentWatch – Mounjaro (tirzepatide)